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Abstract Osmomechanical stress, resulting in cell swelling and
activation/regulation of numerous cellular processes, may play a
critical role in cell signaling by selectively regulating transloca-
tion of protein kinase C (PKC) isoforms from cytosol to mem-
brane compartments. Western blotting of renal epithelial cell
fractions demonstrated the expression of ¢ve PKC isoforms.
Three of these isoforms (PKCK, PKCO, PKCj) translocated
to the membrane fraction upon exposure of cells to osmome-
chanical stress (hypotonic medium). Immunohistochemical stain-
ing of cells using isoform-speci¢c antibodies further demon-
strated translocation of the phorbol ester-sensitive isoforms,
PKCK and PKCO, to both the plasma membrane and perinu-
clear sites, re£ecting potential initial steps in regulation of spe-
ci¢c e¡ector pathways. Indeed, selective inhibition of PKCs in-
dicates a potential role for PKCK in modulating a calcium
in£ux channel. It is concluded that osmomechanical stress in-
duces selective translocation of speci¢c PKC isoforms, demon-
strating a key role of osmomechanical stress in selectively reg-
ulating PKC-dependent signaling pathways.
) 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
The protein kinase C (PKC) isozymes represent a large
family of protein kinases that play central roles in signal
transduction pathways associated with neurotransmitters,
peptide hormones, and growth factors [1,2]. The coupling of
PKCs to initiating signals and transduction pathways is noto-
riously diverse leading to a broad range of functions regu-
lated/modulated by PKCs, including cell proliferation and mi-
gration [1,2], vasoconstriction [3], secretion [4], cell shape and
volume [5,6], and solute transport [2,7,8]. Part of this diversity
is due to the diverse properties of the PKC isoforms them-
selves. There are 11 known mammalian isoforms of PKC that
are typically divided into three groups according to the struc-
tural/functional domains of the regulatory subunit [1,2] : (1)
the conventional PKCs, cPKCs (K, LI, LII and Q isoforms);
(2) the novel PKCs, nPKCs (O, N, R, and a isoforms); and (3)
the atypical PKCs, aPKCs (j, V, and S isoforms). The cPKCs
are activated by Ca and diacylglycerol (DAG)/phorbol esters,
the nPKCs by DAG/phorbol esters only and not by Ca, and
the aPKCs are not sensitive to either Ca or DAG/phorbol
esters. A related kinase that was initially considered part of
the PKCs, PKCW, is often considered to be a distantly related
isozyme that may belong to a separate family (PKD). Its
mode of regulation is poorly understood.
In recent years it has become apparent that the role of
PKCs in signal transduction may extend beyond the simple
ligand/receptor-coupled transduction pathways. Indeed, it has
been shown that mechanical stimuli, such as membrane
stretch or shear stress, are often linked in diverse ways
through various transduction molecules and pathways within
most cells [5,9,10]. Most recently it has been demonstrated
that osmomechanical stress, such as hypotonic-induced cell
swelling, may itself be a major stimulus regulating numerous
processes in the cell including proliferation, growth, secretion,
and cell volume/shape [5,11,12]. In some cases it has been
demonstrated that PKCs may be central for regulating/mod-
ulating the osmomechanically induced processes. It has been
shown that PKCs may underlie numerous processes modu-
lated by osmomechanical stress including osmomechanical
modulation of Ca channels [13,14], anion channels [15,16],
mitogen-activated protein kinase cascades [5,17], and hor-
mone secretion [18] to name a few. Hence, it is becoming
apparent that osmomechanical transduction pathways are a
central component of most cells and that the control of the
associated transduction pathways may, in numerous cases, be
modulated by PKC isozymes.
The purpose of the current study was to determine if osmo-
mechanical stress, leading to cell swelling, di¡erentially con-
trols the translocation and distribution of speci¢c PKC iso-
forms as a potential step in PKC activation. Renal epithelial
cells were utilized as it has been shown that osmotic swelling
of these cells leads to activation of phospholipase C to gen-
erate DAG [13,19] and, in turn, PKC-dependent processes,
including a swelling-activated calcium channel [14,20]. The
function of speci¢c PKC isoforms in these cells is currently
unknown.
2. Materials and methods
2.1. Cell culture
Rabbit proximal tubule cells (PT cells) were isolated according to
the methods of [21], as we have previously done [13,20]. Cells were
grown to con£uence in 100U20-mm dishes (Corning Glass Works,
Corning, NY, USA) or on coverslips (see below) in Dulbecco’s modi-
¢ed Eagle’s medium/Ham’s F-12 nutrient mixture (Sigma, St. Louis,
MO, USA) supplemented with 10% fetal bovine serum (Life Technol-
ogies, Gaithersburg, MD, USA), 1.06 g/l NaHCO3, 100 000 U/l pen-
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icillin G sodium (Gibco BRL, Gaithersburg, MD, USA), 100 mg/l
streptomycin sulfate (Gibco BRL), 10 mg/l gentamicin (Sigma), 50
WM hydrocortisone, 10 mg/l transferrin, and 5 mg/l insulin. The cells
were incubated in a humidi¢ed atmosphere of air and 5% CO2 at
37‡C. Cell passages 4^7 were used in the present study.
2.2. Experimental protocol
The e¡ects of osmomechanical stress due to swelling on PKC iso-
form distribution among di¡erent cellular compartments were deter-
mined. Three treatment groups of PT cells were used. The ¢rst treat-
ment group was treated only with isotonic bathing medium and was
considered as control (ISO, 310 mOsm/kg water). The ISO solution
contained (in mM): 110 NaCl, 4.2 KCl, 0.4 Na2HPO4, 0.5 NaH2PO4,
1.0 CaCl2, 0.3 MgSO4, 20 HEPES, and 90 mannitol, pH 7.4. The
second group was treated with hypotonic bathing medium (HYPO,
220 mOsm/kg water) to induce cell swelling. The HYPO solution was
identical to the ISO solution except that the mannitol was removed to
reduce the osmolality to 220 mOsm/kg. The third group was treated
with phorbol 12-myristate 13-acetate (PMA) (Sigma) in isotonic bath-
ing medium to directly activate PKC (PMA group). The cells were
then harvested and fractionated as described below.
2.3. Cell fraction preparation
Con£uent PT cells were washed twice with room temperature phos-
phate-bu¡ered saline (PBS) and incubated with isotonic solution ^
Hanks’ balanced saline solution (HBSS) adjusted with mannitol to
307 mOsm ^ for 45 min at room temperature. HBSS contains 0.1 M
NaCl, 4.2 mM KCl, 0.4 mM Na2HPO4, 0.5 mM NaH2PO4, 0.3 mM
MgCl2, 0.4 mM MgSO4, and 20 mM HEPES, pH to 7.4. The
cells were then exposed to the various treatments: ISO, HYPO
(5 min) or PMA (1 WM, 10 min). After treatment, the cells were
scraped with ice-cold homogenization bu¡er (20 mM Tris^HCl, 0.5
mM EDTA, 0.5 mM EGTA, 2 mM dithiothreitol, 300 mM sucrose,
10 Wg/ml pepstatin, 1 Wg/ml leupeptin, and 25 Wg/ml aprotinin, pH to
7.4). The cell suspension was centrifuged at 500Ug for 5 min at 4‡C,
the pellet was resuspended in the homogenization bu¡er and minced
via 15^16 strokes in the prechilled homogenizer in the ice bucket. The
total cell fraction homogenate was centrifuged again at 145 000Ug for
30 min at 4‡C. The supernatant was used as the cytosolic fraction.
The pellet, the microsomal fraction, was resuspended and incubated in
the homogenization bu¡er containing 1% Triton X-100 under con-
stant shaking for 30 min at 4‡C. The Triton X-100 extract underwent
centrifugation at 145 000Ug for 30 min at 4‡C. The supernatant was
used as the microsomal membrane fraction. The pellet was discarded.
Finally, total amounts of protein in the microsomal fraction and
cytosolic fraction of PT cells were quanti¢ed using the BCA assay
reagent kit (Pierce, Rockford, IL, USA) according to the manufactur-
er’s instruction.
2.4. Western blotting analysis of PKC isoform
Equal amounts of microsomal and cytosolic proteins (5 Wg or 10
Wg) from each sample were separated by 7.5% sodium dodecyl sulfate^
polyacrylamide gel electrophoresis and transferred onto activated
polyvinylidene di£uoride (PVDF) membrane (Millipore, Bedford,
MA, USA). After transfer, the PVDF membranes were blocked in
5% non-fat milk in PBS at 4‡C overnight. Primary antibodies for
each PKC isoform (PKCK, LI, LII, Q, O, N, R, a, j, V, and S) and
PKCW (Santa Cruz Biotechnology, Santa Cruz, CA, USA) diluted
1:1000 in 2.5% non-fat milk in PBS^Tween were used for immuno-
blotting. The membranes were probed with primary antibody for 1 h
with mild shaking at room temperature followed by three washes with
PBS^Tween for about 30 min. The blots were incubated with horse-
radish peroxidase-conjugated anti-rabbit or anti-mouse IgG (1:5000)
(Amersham Life Science, Arlington Heights, IL, USA), as appropri-
ate, as the secondary antibody for 1 h at room temperature. After
extensive washes with PBS^Tween for about 30 min, the bound anti-
bodies was visualized on ECL Hyper¢lm (Amersham), using an ECL
detection reagent chemiluminescence system (Amersham). The quan-
ti¢cation of the appropriate PKC bands was done by densitometry
reading on Hewlett Packard Version 2.2 ScanJet 3c/T. The signals
were then analyzed by Sigma Gel (Jandel Scienti¢c, San Rafael,
CA, USA) and the densities expressed in arbitrary units.
2.5. Immuno£uorescent assessment of PKCK and PKCO translocation
Only two DAG-sensitive PKC isoforms, PKCK and PKCO, were
shown to be sensitive to osmomechanical stress based on cell fraction-
ation and Western blot studies (see Section 3). To assess further the
translocation of these two isoforms, additional immuno£uorescent
microscopy studies were done to de¢ne the distributions of the iso-
forms. PT cells were grown to con£uence in the four-well chamber
slides. The cells were washed twice with isotonic room temperature
PBS before undergoing the di¡erent treatments. The cells were divided
into the three treatment groups: the ¢rst two wells were bathed in
ISO, the third well was bathed in HYPO, whereas the fourth well was
bathed in ISO with 1 WM PMA. Cells were incubated in each test
solution for 5 min, typically (3-min and 15-min treatments were used
in a few studies), to test if there was any change in PKC localization
in the subcellular level over this time period. At the end of the treat-
ment the solutions were immediately removed from the chamber slides
and 4% paraformaldehyde was added for 15 min at room temperature
to ¢x the cells. After ¢xation the cells were extensively washed with
PBS twice for 30 min at room temperature. The cells were then per-
meabilized with a 50:50 mixture of methanol and acetone for 60 s
followed by PBS washes, twice, over 15 min. Next the cells were
blocked with 1:50 normal goat serum (NGS) in PBS for 1 h at
room temperature, and subsequently incubated with the primary anti-
body in a NGS and PBS mixture (1:50) overnight at 4‡C. The same
polyclonal rabbit anti-PKCK/O antiserum as in the Western blots was
used in the current study. The next day cells were washed with PBS^
0.1% bovine serum albumin (BSA), twice, over 60 min, with rocking,
at room temperature. Oregon green-conjugated goat anti-rabbit anti-
body was then applied at a concentration of 1:300 in PBS^0.1% BSA
to the cells for 1 h at room temperature. All procedures were pro-
tected from light from this point on. Following two washes with PBS^
0.1% BSA and a 5-min wash with PBS at room temperature, the cells
were counterstained with Hoechst dye (1:200 in PBS) for 60 s, and
again washed with PBS and distilled water for 10 min each. Finally,
coverslips were placed over the cells and the cells photographed using
a Nikon Optiphot2 microscope equipped for epi£uorescence.
2.6. Measurement of intracellular calcium levels
Intracellular calcium levels were measured with the calcium-sensi-
tive £uorescent Fura 2 probe using standard techniques as done be-
fore [13,14]. Cells on coverslips were loaded with Fura 2/AM for 45
min, washed, and mounted on the microscope stage of a £uorescent
imaging workstation (Intracellular Imaging) at room temperature.
Cells were repetitively excited at 340 nm and 380 nm and the emission
at 511 nm ratioed to provide a measure of intracellular calcium levels
as outlined previously [13,14]. In a typical experiments, cells were
initially bathed with the ISO solution (see above) for a control period
(10^20 min) and then subjected to test conditions (10^20 min) by
either addition of HYPO medium, to induce osmotic swelling, or
addition of the DAG analogue, 1-oleoyl-2-acetyl-sn-glycerol (OAG,
2 WM), to activate PKCs. Both test conditions have been shown to
activate Ca in£ux and, hence, rapidly increase intracellular Ca levels
[13,14]. Intracellular Ca measurements were made continuously
throughout the control and test periods.
2.7. Statistical analysis
Statistical analysis was performed with the SigmaStat program
(Jandel Scienti¢c), using one-way ANOVA followed by the Student^
Newman^Keuls t-test to determine signi¢cance. The data are pre-
sented as meansSS.E.M. P6 0.05 was considered signi¢cant.
Fig. 1. Summary of PKC isoform Western blot analysis. Immuno-
blots of eight PKC isoforms identi¢ed in rabbit PT epithelial cells
showing distribution patterns for membrane (M) and cytosolic (C)
fractions. Each isoform is indicated along with approximate molecu-
lar weight. The most abundant isoforms were PKCK, O, W, a and j,
while PKCN, R, and V were detectable at low levels. Four other iso-
forms, PKCLI, LII, Q, and S, were typically not detected.
FEBS 27036 3-3-03 Cyaan Magenta Geel Zwart
X. Liu et al./FEBS Letters 538 (2003) 101^106102
3. Results and discussion
3.1. Distribution of PKC isoforms in PT cells
PKC isoforms were found to be widely expressed in PT
cells. Based on Western blots of cell fractions, the abundance
and distribution of all 11 PKC isoforms and PKCW were
evaluated in the PT epithelial cells. Five isoforms were abun-
dantly expressed as shown in the summary data in Fig. 1 and
Table 1. PKC isoforms K, O, a, j and W were readily detected
in both cytosolic and plasma membrane fractions of control
(ISO) cells. In contrast, PKCLI, LII, Q, and S isoforms were
not detectable in either fraction demonstrating little if any
expression of these isoforms in these cells under the current
conditions. Similarly, PKCV, N, and R isoforms were normally
not detectable in membrane and cytosolic fractions, although
low-density bands were occasionally evident in membrane
fractions only (see Fig. 1). The expression of these latter iso-
forms was not su⁄cient to assess HYPO-induced transloca-
tion from the cytosol to the plasma membrane with current
techniques and, hence, these isoforms were not studied fur-
ther.
Finally, of the ¢ve isoforms abundantly expressed in the PT
cells, the speci¢city of the primary antibodies to the isoforms
was assessed by competitive binding of a blocking peptide to
the antibody. After detecting appropriate bands on Western
blots with the primary antibody, the PVDF membranes were
stripped and the primary antibody reapplied to the same
PVDF membranes, but in the presence of the appropriate
blocking peptide. In all cases the appearance of the isoform
bands was signi¢cantly diminished as demonstrated by the
example for PKCK in Fig. 2A (inset).
3.2. E¡ect of osmomechanical stress on PKC isoform
translocation
The e¡ect of osmomechanical stress on PKC isoform dis-
tribution between cytosol and cell membrane was determined
by exposing the cells to HYPO. After treatment of cells with
HYPO for 5 min, the cells were fractionated and isoform
Table 1
Summary of PKC isoform Western blot analysis in PT cellsa
PKC subfamily Isoform Identi¢ed
Conventional K ++
LI 3
LII 3
Q 3
Novel N +
O ++
R +
a ++
Atypical j ++
V +
S 3
PKCW (PKD) W ++
++: Isoform detected in both membrane and cytosolic fractions;
+: isoform detected in membrane fraction only of at least one blot;
3 : isoform not detectable in either membrane or cytosolic fractions.
aTwo to nine blots were analyzed for each isoform.
Fig. 2. Immunoblots of PKC isoforms from cells treated with HYPO or PMA. Con£uent PT cells were treated with isotonic solution (ISO),
hypotonic solution (HYPO, 220 mOsm/l) or PMA (1 WM) in ISO for 5, 5, and 10 min, respectively, and membrane and cytosolic fractions col-
lected and immunoblotted. Fractions were probed with speci¢c anti-PKC antibodies: (A) PKCK (n=4), (B) PKCO (n=6), (C) PKCj (n=5),
(D) PKCa (n=4), (E) PKCW (n=5). Only bands from the same gel were compared. All values shown are arbitrary densitometric units ex-
pressed as ratio fold of membrane vs. cytosolic fractions. Gel shown in inset is a representative Western blot of respective PKC isoform with
the following loading sequence: IM: ISO membrane fraction. IC: ISO cytosolic fraction. HM: HYPO membrane fraction. HC: HYPO cyto-
solic fraction. PM: PMA membrane fraction. PC: PMA cytosolic fraction. ‘K+bp’ (A) is the PKCK antibody with a speci¢c blocking peptide
(bp) for PKCK. *P6 0.05 HYPO compared to ISO; **P6 0.05 PMA compared to ISO.
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distribution assessed via Western blotting. As shown by the
data in Fig. 2, two DAG-sensitive isoforms were shown to be
sensitive to HYPO treatment. Both PKCK (Fig. 2A) and
PKCO (Fig. 2B) displayed a translocation to the plasma mem-
brane following HYPO as compared to cells treated only with
ISO, demonstrating osmomechanical control of the distribu-
tion of these two isoforms. The increase for PKCK was mod-
est, increasing by 40S10%, while that for PKCO was more
substantial, increasing by 253S 68%. Since these two isoforms
belong to the DAG-sensitive groups, cPKC and nPKC, re-
spectively, we tested to determine if PMA similarly would
activate the translocation of these two isoforms. Indeed, as
expected, PMA treatment (1 WM, 10 min) resulted in a major
shift of these isoforms from the cytosol to the membrane
fraction, increasing by over 11-fold (Fig. 2A) and 22-fold
(Fig. 2B), respectively.
The aPKC, PKCj, was also found to be sensitive to osmo-
mechanical stress. As shown in Fig. 2C, a signi¢cant mem-
brane translocation of PKCj occurred in the HYPO treat-
ment group (166S 28% increase) compared with the control
ISO group. Treatment with PMA had little e¡ect, as expected,
for a DAG-insensitive isoform. It was somewhat unexpected
to observe a sensitivity of PKCj to HYPO in these cells as it
is often considered that HYPO-induced processes in these cells
are regulated via DAG-sensitive PKCs [13]. The signi¢cance
of this response is currently not known.
Some PKCs were found to be insensitive to osmomechan-
ical stress. As shown by the example in Fig. 2D, the distribu-
tion of PKCa was not sensitive to HYPO treatment, nor to
PMA treatment. Similarly, the distribution of PKCW (Fig. 2E)
or PKD was not altered by HYPO treatment although a small
stimulation by PMA treatment was evident. Hence, not all
PKC isoforms are regulated by osmomechanically controlled
signaling pathways.
The present study demonstrates, for the ¢rst time, that os-
motic cell swelling alone can lead to selective translocation
and distribution of speci¢c PKC isoforms to cell membrane
domains. The three PKC isoforms observed to partition to the
cell membranes, namely PKCK, PKCO, and PKCj, represent
isoforms from each of the three families of PKC, cPKC,
nPKC, and aPKC, respectively. Hence, translocation and dis-
tribution of the isoforms is not a property of the type of PKC
regulatory domain per se, but may re£ect activation of multi-
ple regulatory pathways important for each of the isoform
subfamily members.
3.3. Immuno£uorescent assessment of PKCK and
PKCO distribution
It has been shown previously in PT cells that osmomechan-
ical stress leads to activation of plasma membrane Ca chan-
nels through DAG-sensitive PKC pathways [13,14]. Of the
three osmomechanically sensitive PKCs identi¢ed in the
present study, two are DAG-sensitive, PKCK and PKCO. To
assess the potential cellular sites of activation of these two
isoforms and, hence, the types of processes that may be regu-
lated by these isoforms, the subcellular localization of these
two isoforms in the cultured PT cell was determined by im-
muno£uorescent microscopy techniques.
Under control ISO conditions, PKCK appeared to be dif-
fusely distributed throughout the cells (Fig. 3B) with little or
no localization to the plasma membrane. Upon exposure to
HYPO treatment (Fig. 3C) for 5 min, a redistribution of the
isoform was apparent with modest translocation to both the
plasma membrane (small arrows) and the perinuclear area
(large arrowheads). The dominant redistribution, however,
was to the perinuclear area, likely re£ecting localization to
the endoplasmic reticulum/Golgi/nuclear membranes. Hence,
HYPO-induced translocation of PKCK to the plasma mem-
brane, while evident, appears to re£ect only a modest compo-
nent of the isoform translocation following HYPO exposure.
In contrast, when cells were exposed to PMA treatment, a
marked redistribution of PKCK to both the plasma membrane
and perinuclear area was apparent (Fig. 3D). To determine if
the redistribution patterns were altered over several minutes
of exposure to each treatment, the above 5-min treatment
conditions were compared to treatment periods of 3 and 15
min. No obvious alterations in distribution were apparent
during these time periods (data not shown).
The distribution of PKCO was also found to be sensitive to
HYPO treatment. Under control ISO conditions the isoform
was di¡usely distributed throughout the cell with no apparent
plasma membrane localization (Fig. 4B). Upon exposure to
HYPO treatment for 5 min (Fig. 4C), PKCO demonstrated a
signi¢cant translocation to both the plasma membrane (small
arrows) and the perinuclear area (large arrowheads). In addi-
tion, the isoform distribution within the cytoplasm also dis-
played a weak reticular pattern consistent with modest redis-
tribution to cytoskeletal structures. HYPO treatment would
appear to lead to redistribution of the isoform to several key
sites within the cell, likely re£ecting a regulatory role in multi-
ple cellular processes. Finally, with PMA treatment, PKCO
redistribution followed the same pattern as that observed
with HYPO treatment, but with a more extensive redistribu-
tion (Fig. 4D). Similar to that observed with PKCK, treatment
of cells for 3 or 15 min did not obviously alter the distribution
patterns of PKCO (data not shown).
Fig. 3. Immuno£uorescent images of PKCK distribution. The cells
were grown to con£uence in four-well chamber slides followed by
treatments with ISO, HYPO, or PMA solutions, respectively, for
5 min. Cells were then immunostained for PKCK using the anti-
PKCK antibody and photographed using a Nikon Optiphot2 micro-
scope equipped for epi£uorescence (magni¢cation 20U) as described
in Section 2. Small arrows indicate plasma membrane localization
and large arrowheads indicate perinuclear localization. CTL: control
without primary antibody; ISO: isotonic treatment; HYPO: hypo-
tonic treatment; PMA: PMA treatment.
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Regulation of PKC isoform translocation and activation is
thought to be a relatively speci¢c process that is typically
localized to speci¢c subcompartments within the cell thereby
resulting in selective activation of pathways within the sub-
compartments. This subcompartment speci¢city may result
from regulation of protein tra⁄cking to distinct sites, as pre-
viously demonstrated [22]. Alternatively, the speci¢city may
be controlled by binding proteins or receptors for PKCs, the
receptor-activated C kinases (RACKs) [23], as the location of
the RACKs can provide the compartmental speci¢city. The
role of RACKs in regulating PKC activation in PT cells is not
known. However, it was shown for the ¢rst time in the present
study that PKCK and PKCO are translocated to speci¢c sites
within the cells following HYPO-induced or PMA-induced
activation. Both isoforms appear to distribute to sites within
the plasma membrane and to perinuclear regions, common
sites of translocation for some PKC isoforms [24^26], and
likely leads to phosphorylation of signaling components at
these localized sites which, in turn, regulate downstream ef-
fectors such as plasma membrane ion channels or signaling
pathways modulating gene expression, respectively.
3.4. PKCK regulation of calcium in£ux
As heretofore noted, osmomechanical stress activates a Ca
in£ux pathway through a PKC-dependent mechanism in the
renal cells [13,14,20]. Since OAG, a DAG analogue, and PMA
can also activate this pathway [14], it is likely that the DAG-
sensitive PKCs, such as PKCK or PKCO, regulate calcium
in£ux. As an initial assessment of PKCK or PKCO speci¢city
for this pathway, the e¡ects of selective PKC inhibitors on Ca
in£ux were determined using the change in intracellular Ca
levels following activation by HYPO or OAG (2 WM) as an
index of Ca in£ux as done before [13,14]. (That is, stimulation
of Ca in£ux through the native Ca channels by HYPO or
OAG treatment would lead to a rapid rise in intracellular
Ca levels while inhibition of the Ca in£ux channels would
lead to depressed intracellular Ca levels.) Intracellular calcium
levels were measured via the Fura 2 £uorescence method.
Addition of Go 6976 (Calbiochem) (200 nM), a relatively
speci¢c blocker of PKCK (over PKCO), signi¢cantly reduced
the normal OAG-induced peak change in calcium from
252S 29 nM (n=6) to 115S 25 nM (n=6) after Go addition
(P6 0.05), and the HYPO-induced change from 99S11 nM
(n=7) to 64S 6 nM (n=7) after Go addition (P6 0.05).
Hence, Go 6976 treatment reduced the stimulated Ca in£ux.
In contrast, addition of Ro-31-8425 (Calbiochem), a more
general blocker of PKCO and similar PKCs, did not further
reduce Ca in£ux, i.e. it did not further reduce intracellular Ca
levels (data not shown). Hence, these initial studies point to a
speci¢c role for PKCK in regulating HYPO-induced Ca in£ux
in these cells.
In summary, it has been shown that osmomechanical stress
is an important ‘signaling’ component controlling transloca-
tion of speci¢c PKC isoforms. Speci¢c PKC isoforms from all
three subfamilies of PKC, namely cPKC, nPKC, and aPKC,
were shown to be sensitive to swelling-induced states. The
distribution patterns of translocation included plasma mem-
branes, perinuclear membranes, and cytoskeletal structures,
demonstrating a broad array of processes likely controlled
by these isoforms during osmomechanical stress. While some
of the processes regulated by these isoforms is known, such as
swelling-activated calcium channels and the associated calci-
um signaling, other processes controlled by these isoforms are
yet to be de¢ned.
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